Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2013
10/01/2013US8545884 Solid pharmaceutical formulations comprising BIBW 2992
10/01/2013US8545881 Orally disintegrating tablets and methods of manufacture
10/01/2013US8545880 Controlled release oral dosage form
10/01/2013US8545879 Fast disintegrating compositions of meloxicam
10/01/2013US8545877 Modified drugs for use in liposomal nanoparticles
10/01/2013US8545875 Nanolipidic particles
10/01/2013US8545874 Method for making nanolipidic particles
10/01/2013US8545873 Percutaneous absorption type plaster
10/01/2013US8545872 Device for the transdermal administration of a rotigotine base
10/01/2013US8545870 Medicinal table with prolonged release of the active principle
10/01/2013US8545832 Lipid depot formulations
10/01/2013US8545831 Compositions and methods for treating a damaged cardiovascular element
10/01/2013US8545830 Smart segment and a hydrophobic and a hydrophillic biodegradable segment which are hydrolytically or enzymatically degradable; prolonged delivery of therapeutic agents
10/01/2013US8545829 Pharmaceutical preparations for oral administration, containing ion-exchange resins loaded with active ingredients and intrinsically viscous gelling agents as thickening agents
10/01/2013US8545821 Cosmetic use of water-redispersible powders
10/01/2013US8545550 Drug-delivery endovascular stent and method for treating restenosis
10/01/2013CA2776407C Method of preparing sitagliptin and intermediates used therein
10/01/2013CA2750626C High dosage doramectin formulation
10/01/2013CA2737335C 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases
10/01/2013CA2735844C Use of piperine and analogues thereof in the prevention of skin cancer
10/01/2013CA2732950C Imidazopyridin-2-one derivatives
10/01/2013CA2731067C Compositions and methods for treating osteoarthritis
10/01/2013CA2730715C Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine
10/01/2013CA2723545C 6-pyridin-3-yl-3,4-dihydro-1h-quinolin-2-one derivatives and related compounds as inhibitors of the human aldosterone synthase cyp11b2
10/01/2013CA2720516C Indoline anti-cancer agents
10/01/2013CA2719876C Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/01/2013CA2710959C Imidazole carbonyl compounds and use thereof for treating bacterial infections
10/01/2013CA2694242C Process for introduction of hydroxyethoxy side chain in bosentan
10/01/2013CA2681545C Fluorinated derivatives of deferiprone
10/01/2013CA2673924C Liposomal pharmaceutical preparation and method for manufacturing the same
10/01/2013CA2672155C Use of xanthohumol or isoxanthohumol as an active substance for the prevention and/or control of liver diseases
10/01/2013CA2655809C Dermal anesthetic compounds
10/01/2013CA2644848C Compositions and methods for enhancing the antioxidant status of animals
10/01/2013CA2644143C Combinations comprising bcr-abl/c-kit/pdgf-r tk inhibitors for treating cancer
10/01/2013CA2642241C New stable hyperbaric composition comprising prilocaine hcl, use of said new composition for intrathecal anaesthesia, and method for manufacturing said composition
10/01/2013CA2633374C Amine compound and use thereof for medical purposes
10/01/2013CA2632198C Pharmaceutical formulation containing phenytoin sodium and magnesium stearate
10/01/2013CA2625532C Agent for applying to mucosa containing a hydrophobic group binding type glycosaminoglycan
10/01/2013CA2624909C Therapeutic agent for treating liver disease containing 2-amino-1,3-propanediol derivative as active ingredient, and method for treating liver disease
10/01/2013CA2620034C Diaminopyrimidines as p2x3 and p2x2/3 modulators
10/01/2013CA2619010C Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands
10/01/2013CA2615912C Lotion preparation containing pyridonecarboxylic acid derivative
10/01/2013CA2615466C Benzofused five-membered heterocycles as inhibitors of catechol-o-methyltransferase (comt) enzyme
10/01/2013CA2612726C Halogenated pyrazolo [1,5-a]pyrimidines, processes, uses as gaba-a receptors ligand, compositions and intermediates
10/01/2013CA2611713C Treatment of sleep-wake disorders
10/01/2013CA2609726C 17.beta.-hsd1 and sts inhibitors
10/01/2013CA2607934C Method for preparation of optionally 2-substituted 1,6-dihydro-6-oxo-4-pyrimidinecarboxylic acids
10/01/2013CA2605839C Stabilized composition of a proton pump inhibitor
10/01/2013CA2605738C Novel azaheterocyclic compounds as kinase inhibitors
10/01/2013CA2594775C Agents containing folic acid, vitamin b6 and vitamin b12, and the use thereof
10/01/2013CA2594508C Cyanoguanidine compounds
10/01/2013CA2594482C Antitumor agent
10/01/2013CA2591083C Medicaments for the treatment or prevention of fibrotic diseases
10/01/2013CA2589495C 2-arylpropionic acid derivatives and pharmaceutical compositions containing them
10/01/2013CA2579605C Topical compositions and methods for epithelial-related conditions
10/01/2013CA2579279C Tricyclic thiazole derivatives as pi3 kinases
10/01/2013CA2577361C Pharmaceutical composition in the form of a gastric-resident tablet containing an active principle
10/01/2013CA2574335C Veterinary composition comprising an arylpyrazole and a nitroenamine with antiparasitic activity
10/01/2013CA2573386C Composition for promoting vascular smooth muscle relaxation
10/01/2013CA2569743C Opioids for the treatment of the chronic obstructive pulmonary disease (copd)
10/01/2013CA2566161C Aryl ketone compounds and compositions for delivering active agents
10/01/2013CA2565568C Pyrimidines as plk inhibitors
10/01/2013CA2563533C Compositions capable of facilitating penetration across a biological barrier
10/01/2013CA2557845C Process for preparing, and composition and pharmaceutical dosage forms containing, an oxycodone salt having less than 25 ppm 14-hydroxycodeinone
10/01/2013CA2557142C Method for providing antimicrobial composite yarns, composite fabrics and articles made therefrom
10/01/2013CA2553725C Topical compositions combining sodium hyaluronate fragments and a retinoid
10/01/2013CA2541989C P70s6 kinase modulators and method of use
10/01/2013CA2533367C Purine nucleoside analogues for treating flaviviridae including hepatitis c
10/01/2013CA2532152C Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
10/01/2013CA2531507C Pyrimidine-2,4-dione derivatives as gonadotropin-releasing hormone receptor antagonists
10/01/2013CA2529613C Agent for repairing corneal sensitivity containing amide compound
10/01/2013CA2512133C Compositions of arachidonic acid for preventing or alleviating symptoms or diseases due to aging of blood vessels
10/01/2013CA2467689C Stabilization of hypoxia inducible factor (hif) alpha using inhibitors of hif prolyl hydroxylase
10/01/2013CA2451104C Electro-medical device for use with biologics
10/01/2013CA2409643C Improvements in and relating to digestive/laxative compositions
10/01/2013CA2337690C Chemically induced intracellular hyperthermia
10/01/2013CA2239448C Blockade of t lymphocyte down-regulation associated with ctla-4 signaling
09/2013
09/30/2013CA2810732A1 Compositions and method for improving endothelial function and cardiovascular health
09/26/2013WO2013142875A1 Treatment of brain cancer
09/26/2013WO2013142831A1 Methods of making and using thioxothiazolidine and rhodanine derivatives as hiv-1 and jsp-1 inhibitors
09/26/2013WO2013142817A2 Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigo
09/26/2013WO2013142816A1 Compounds and compositions for the treatment of muscular disorders
09/26/2013WO2013142812A1 Antibacterial agents: sidechain-fluorinated myxopyronin derivatives
09/26/2013WO2013142721A1 Compositions and methods for preventing or treating acute kidney injury using proton pump inhibitors
09/26/2013WO2013142712A1 Antimicrobial agents
09/26/2013WO2013142669A1 Method of modulating ribonucleotide reductase
09/26/2013WO2013142654A2 Compositions for delivering perfume to the skin
09/26/2013WO2013142628A2 Antibiotic compounds and compositions, and methods for identification thereof
09/26/2013WO2013142613A1 Spirocyclic dihydro-thiazine and dihydro-oxazine bace inhibitors, and compositions and uses thereof
09/26/2013WO2013142525A1 Substituted nucleosides, nucleotides and analogs thereof
09/26/2013WO2013142514A1 Methods and compositions for modulating alpha-1-antitrypsin expression
09/26/2013WO2013142509A1 ANTISENSE MODULATION OF HYPOXIA INDUCIBLE FACTOR 1 ALPHA (HIFIα) EXPRESSION
09/26/2013WO2013142491A1 Methods of treating cancer using aurora kinase inhibitors
09/26/2013WO2013142490A2 Tauroursodeoxycholic acid attenuates or abolishes formation and deposition of amyloid-b peptide
09/26/2013WO2013142427A1 Compounds and methods for kinase modulation, and indications therefor
09/26/2013WO2013142424A1 Beta-hydroxy-beta-methylbutyric acid for improving glucose tolerance
09/26/2013WO2013142396A1 N3-substituted iminopyrimidinones as renin inhibitors, compositions, and their use
09/26/2013WO2013142383A1 Topically administered strontium-containing complexes for treating pain, pruritis and inflammation
09/26/2013WO2013142382A1 Substituted pyridopyrimidine compounds and their use as flt3 inhibitors
09/26/2013WO2013142376A1 Composition and methods for cell modulation
1 ... 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 ... 7860